Fundraising FoxFuse Oncology
Greensboro, US · Founded 2021 · 2 known investors
Find your way into Fuse Oncology
Sign up to see every warm intro you have to Fuse Oncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fuse Oncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fuse Oncology offers an AI-based software suite for radiation oncology that handles treatment planning, prior authorization, clinical documentation, charge-capture billing, and analytics. It serves clinicians and administrators at hospitals and cancer treatment facilities, aiming to shorten the time from consult to treatment.
Founders & leadership
Investors · 2
How we know: First Trust Capital Partners's portfolio page · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$11.8M disclosed across 2 rounds · 2021–2023
▶$8.9MraisedApr 2023 · 20 investors · Other Health CareRule 506(b)
- John MillerDirector
- Jay BrennanDirector
- Benjamin SintayExecutive Officer
- John StriderExecutive Officer
- James BaulerExecutive Officer, Director
- David WiantExecutive Officer
- Offering amount
- $9.7M
- Amount sold
- $8.9M
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$3MraisedMay 2022 · 18 investors · Other Health CareRule 506(b)
- John MillerDirector
- John StriderExecutive Officer
- Benjamin SintayExecutive Officer
- Jay BrennanDirector
- James BaulerExecutive Officer
- David WianttExecutive Officer
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $25K
- Proceeds to insiders
- $150K
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Fuse Oncology do?
- Fuse Oncology offers an AI-based software suite for radiation oncology that handles treatment planning, prior authorization, clinical documentation, charge-capture billing, and analytics. It serves clinicians and administrators at hospitals and cancer treatment facilities, aiming to shorten the time from consult to treatment.
- Who are Fuse Oncology's investors?
- Fuse Oncology's investors include First Trust Capital Partners, First Launch Capital.
- How much funding has Fuse Oncology raised?
- Fuse Oncology has disclosed $11.8M raised across 2 rounds.
- Where is Fuse Oncology headquartered?
- Fuse Oncology is headquartered in Greensboro, US.